Go Deep
Ribomic Inc.
Ribomic Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,080 | -2.8 | 1.32 | 0.00 | 38.74 |
| Oct 2026 | 19,987 | -2.9 | 1.36 | 0.00 | 39.88 |
Ribomic Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 4,500,000.0 | 2,250,000.0 | 750,000.0 | 0.0 |
| Net Profit | -270,997,000.0 | -382,069,000.0 | -249,122,000.0 | -286,722,000.0 |
| EPS | -4.9 | — | — | — |
Ribomic Inc. Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 3,000,000.0 | 2,107,000.0 | 0.0 | 65,969,000.0 |
| Net Profit | -1,145,360,000.0 | -1,018,939,000.0 | -1,024,237,000.0 | -1,653,002,000.0 |
| EPS | -23.1 | -25.2 | -28.7 | -53.1 |
Ribomic Inc. Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 2,976,215,000.0 | 3,185,842,000.0 | 3,547,257,000.0 | 4,583,655,000.0 | — |
| Total Liabilities | 135,092,000.0 | 142,210,000.0 | 155,809,000.0 | 199,304,000.0 | — |
| Total Equity | 2,841,123,000.0 | 3,043,632,000.0 | 3,391,448,000.0 | 4,384,351,000.0 | — |
Owes vs Owns
Ribomic Inc. owed ¥0.05 for every ¥1 it owned in Jun 2026, up from ¥0.04 in Mar 2023.
| Period | Jun 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.05× | 0.05× | 0.04× | 0.04× | 0.04× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Ribomic Inc. Assets & Liabilities Breakdown (JPY millions)
What it owns — Mar 2026
Cash & short-term investments 95.0%Long-term investments 0.8%Other assets 3.8%
How it's funded — Mar 2026
Payables 3.1%Other liabilities 1.4%Shareholders' equity 95.5%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 2,827.2 | 3,037.1 | 3,399.7 | 4,325.2 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 2.6 | 3.7 | 2.3 | 2.1 |
| Fixed assets (tangible) | 11.3 | 11.3 | 11.3 | 11.3 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 22.6 | 22.6 | 22.6 | 22.6 |
| Other assets | 112.5 | 111.2 | 111.4 | 222.5 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 93.2 | 109.7 | 98.0 | 155.2 |
| Other liabilities | 41.9 | 32.5 | 57.8 | 44.1 |
| Shareholders' equity | 2,841.1 | 3,043.6 | 3,391.4 | 4,384.4 |
| Net tangible assets | 2,841.1 | 3,043.6 | 3,391.4 | 4,384.4 |
Ribomic Inc. Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -1,110,863,000.0 | -996,966,000.0 | -932,757,000.0 | -1,708,626,000.0 | — |
| Investing Activities | 289,832,000.0 | 67,178,000.0 | 177,272,000.0 | 276,353,000.0 | — |
| Financing Activities | 911,054,000.0 | 667,263,000.0 | 27,649,000.0 | 1,333,771,000.0 | — |